Natural autoantibody to galectin-9 in normal human sera

Journal of Clinical Immunology

Volumn 19, Issue 3, 1999, Pages 158-165

  Suk, Kyoungho ^a   Hwang, Dae Yeon ^a   Lee, Myung Shik ^a,b  

^a Samsung Medical Center   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Autoantibody; cDNA library; Galectin 9; Isoform; Pancreatic islets

Indexed keywords

AUTOANTIBODY; ECALECTIN; GALECTIN; LACTOSE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; DNA LIBRARY; FEMALE; HELA CELL; HUMAN; IMMUNOLOGY; IMMUNOPRECIPITATION; IMMUNOREGULATION; LEUKEMIA CELL LINE; LIVER; LUNG; MALE; NORMAL HUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SERUM; TONSIL;

ADULT; AMINO ACID SEQUENCE; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; DNA, COMPLEMENTARY; FEMALE; GALECTINS; GENE LIBRARY; HUMANS; IMMUNOGLOBULIN ISOTYPES; ISLETS OF LANGERHANS; LECTINS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PRECIPITIN TESTS; PROTEIN BIOSYNTHESIS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 0033055646     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020599526249     Document Type: Article

References (35)

1. Rodman TC, To SE, Sullivan JJ, Winston R: Innate natural antibodies. Primary roles indicated by specific epitopes. Hum Immunol 55:87-95, 1997
2. Tomer Y, Shoenfeld Y: The significance of natural autoantibodies. Immunol Invest 17:389-424, 1988
3. Avrameas S: Natural autoantibodies: From "horror autotoxicus" to "gnothi seauton." Immunol Today 12:154-159, 1991
4. Boulila A, Hachicha J, Adyel FZ, Jlidi R, Avrameas S, Ternynck T, Ayadi H: Deposition of anti-actin antibodies in the kidney of a patient with systemic lupus erythematosus under immunosuppressive treatment. Nephrol Dial Transplant 11:2478-2481, 1996
5. Quan CP, Berneman A, Pires R, Avrameas S, Bouvet JP: Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans. Infect Immun 65:3997- 4004, 1997
6. Parker W, Yu PB, Holzknecht ZE, Lundberg K, Buckley RH, Platt JL: Specificity and function of "natural" antibodies in immunodeficient subjects: Clues to B cell lineage and development. J Clin Immunol 17:311-321, 1997
7. Lutomski D, Caron M, Bourin P, Lefebure C, Bladier D, Joubert-Caron R: Purification and characterization of natural antibodies that recognize a human brain lectin. J Neuroimmunol 57:9-15, 1995
8. Lutomski D, Joubert-Caron R, Lefebure C, Salama J, Belin C, Bladier D, Caron M: Anti-galectin-1 autoantibodies in serum of patients with neurological diseases. Clin Chim Acta 262:131-138, 1997
9. Mathews KP, Konstantinov KN, Kuwabara I, Hill PN, Hsu DK, Zuraw BL, Liu FT: Evidence for IgG autoantibodies to galectin-3, a beta-galactoside-binding lectin (Mac-2, epsilon binding protein, or carbohydrate binding protein 35) in human serum. J Clin Immunol 15:329-337, 1995
10. Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Feizi T, Gitt MA, Hirabayashi J, Hughes C, Kasai K, et al.: Galectins: A family of animal beta-galactoside-binding lectins [letter]. Cell 76:597-598, 1994
11. Barondes SH, Cooper DN, Gill MA, Leffler H: Galectins. Structure and function of a large family of animal lectins. J Biol Chem 269:20807-20810, 1994
12. Akahani S, Nangia-Makker P, Inohara H, Kim HR, Raz A: Galectin-3: A novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res 57:5272-5276, 1997
13. Perillo NL, Uittenhogaart CH, Nguyen JT, Baum LG: Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes. J Exp Med 185:1851-1858, 1997
14. Wada J, Ota K, Kumar A, Wallner EI, Kanwar YS: Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J Clin Invest 99:2452-2461, 1997
15. Matsumoto R, Matsumoto H, Seki M, Hata M, Asano Y, Kanegasaki S, Stevens RL, Hirashima M: Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem 273:16976-16984, 1998
16. Eisenbarth GS: Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Medicine 314:1360-1368, 1986
17. Baekkeskov S, Aanstoot, H-J, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olsen H, De Camilli P: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151-156, 1990
18. Rabin DU, Pleasic SM, Palmer-Crocker R, Shapiro JA: Cloning and expression of IDDM-speeific human autoantigens. Diabetes 41:193-186, 1992
19. Rorsman F, Husebye ES, Winqvist O, Bjork E, Karlsson FA, Kampe O: Aromatic-L-amino-acid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a beta-cell autoantigen. Proc Natl Acad Sci USA 92:8626-8629, 1995
20. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanatc-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
21. Gianani R, Rabin DU, Verge CF, Yu L, Babu SR, Pietropaola M, Eisenbarth G: ICA512 autoantibody radioassay. Diabetes 44: 1340-1344, 1995
22. Fushuku N, Murumatsu H, Uezono MM, Muramatsu T: A new endo-beta-galactosidase releasing Gal alpha 1-3Gal from carbohydrate moieties of glycoproteins and from a glycolipid. J Biol Chem 262:10086-10092, 1987
23. Knibbs RN, Perini F, Goldstein IJ: Structure of the major concanavalin A reactive oligosaccharides of the extracellular matrix component laminin. Biochemistry 28:6379-6392, 1989
24. Wada J, Kanwar YS: Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin. J Biol Chem 272:6078-6086, 1997
25. Tureci O, Schmitt H, Fadle N, Pfreundschuh M, Sahin U: Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease. J Biol Chem 272:6416-6422, 1997
26. Abbott WM, Hounsell EF, Feizi T: Further studies of oligosaccharide recognition by the soluble 13 kDa lectin of bovine heart muscle. Ability to accommodate the blood-group-H and -B-related sequences. Biochem J 252:283-287, 1988
27. Oda Y, Herrmann J, Gitt MA, Turck CW, Burlingame AL, Barondes SH, Leffler H: Soluble lactose-binding lectin from rat intestine with two different carbohydrate-binding domains in the same peptide chain. J Biol Chem 268:5929-5939, 1993
28. Leffler H, Barondes SH: Specificity of binding of three soluble rat lung lectins to substituted and unsubstituted mammalian beta-galactosides. J Biol Chem 261:10119-10126, 1986
29. Lee RT, Ichikawa Y, Allen HJ, Lee YC: Binding characteristics of galactoside-binding lectin (galaptin) from human spleen. J Biol Chem 265:7864-7871, 1990
30. Knibbs RN, Agrwal N, Wang JL, Goldstein IJ: Carbohydrate-binding protein 35. II. Analysis of the interaction of the recombinant polypeptide with saccharides. J Biol Chem 268:14940-14947, 1993
31. Drickamer K, Taylor ME: Biology of animal lectins. Annu Rev Cell Biol 9:237-264, 1993
32. Liao DI, Kapadia G, Ahmed H, Vasta GR, Herzberg O: Structure of S-lectin, a developmentally regulated vertebrate beta- galactoside-binding protein. Proc Natl Acad Sci USA 91:1428-1432, 1994
33. Lobsanov YD, Gitt MA, Leffler H, Barondes SH, Rini JM: X-ray crystal structure of the human dimeric S-Lac lectin, L-14-II, in complex with lactose at 2.9-A resolution. J Biol Chem 268:27034- 27038, 1993
34. Sato S, Hughes RC: Binding specificity of a baby hamster kidney lectin for H type I and II chains, polylactosamine glycans, and appropriately glycosylated forms of laminin and fibronectin. J Biol Chem 267:6983-6990, 1992
35. Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits-R, Stenner F, Luo G, Schobert I, Pfreundschuh M: Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92:11810-11813, 1995